Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it is also used in dentistry. Owing to the ubiquity of the trade name Novocain, in some regions, procaine is referred to generically as novocaine. It acts mainly as a sodium channel blocker. Today it is used therapeutically in some countries due to its sympatholytic, anti-inflammatory, perfusion-enhancing, and mood-enhancing effects
Market Analysis and Insights: Global Procaine Market
Due to the COVID-19 pandemic, the global Procaine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Injection accounting for % of the Procaine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Procaine market size is valued at US$ million in 2021, while the US and Europe Procaine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Procaine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Procaine include Eli Lilly and Company, Consolidated Pharmaceutical, Pfizer, Bristol-Myers Squibb, Bel Mar Laboratories, Elkins Sinn, Bayer, Watson Laboratories and RNP Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Procaine Scope and Segment
Procaine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Procaine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injection
Powder
Segment by Application
Hospital
Drug Store
On-line
By Company
Eli Lilly and Company
Consolidated Pharmaceutical
Pfizer
Bristol-Myers Squibb
Bel Mar Laboratories
Elkins Sinn
Bayer
Watson Laboratories
RNP Pharmaceuticals
Tbilchempharma
SÜDmedica Gmbh
Grindeks
Towa Yakuhin
Hikari Seiyaku
Köhler-Pharma
Ardeapharma
Stada
Fuso Pharmaceutical
Hevert-Arzneimittel
Teofarma
Richter Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE